Abstract 271: Monitoring of CCR2 and CCR5 expression on circulating myeloid derived suppressor cells (MDSCs) in non-small cell lung cancer as a correlate of minimum residual disease
Hamza Khan(Johns Hopkins University), Malcolm Brock(Johns Hopkins University), Stephen Broderick(Johns Hopkins University), Maria Shishikura(Johns Hopkins University), Carley Blevins(Johns Hopkins University), Shun Ishiyama(Johns Hopkins University), Franck Housseau(Centre National de la Recherche Scientifique), Hajime Orita(Juntendo University Hospital), Ada Tam(Bloomberg (United States)), Anas H. Awan(Johns Hopkins University), Errol L. Bush(Johns Hopkins University), Wasay Nizam(Johns Hopkins University), Yun Chen(Yale University), Jinny S. Ha(Sidney Kimmel Comprehensive Cancer Center), Yuping Mei(Johns Hopkins Hospital), Richard J. Battafarano(Johns Hopkins University), Kristen Rodgers(Johns Hopkins University), Peng Huang(Johns Hopkins University), Stephen C. Yang(Johns Hopkins University)
Cited by 0
Related Papers
An atlas of active enhancers across human cell types and tissues
|Nature|2014|2.8k
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
|Cancer Discovery|2014|1.5k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k